---
title: 'Director, Medical Writing at Kiniksa Pharmaceuticals'
canonical: 'https://feeny.ai/job/director-medical-writing-kiniksa-pharmaceuticals-lexington-87fpdgh3y7c4'
type: 'job'
last_seen: '2026-10-19'
---

# Director, Medical Writing at Kiniksa Pharmaceuticals

- **Company:** Kiniksa Pharmaceuticals
- **Location:** Lexington, MA
- **Compensation:** $225k–$239k
- **Posted:** 2026-09-25
- **Last confirmed live:** 2026-10-19
- **Apply:** https://job-boards.greenhouse.io/kiniksapharmaceuticals/jobs/4421495009

## Job description

Kiniksa Pharmaceuticals is a commercial‑stage biopharmaceutical company developing and commercializing novel therapies for diseases with unmet need, with a focus on cardiovascular indications. With deep expertise in immunology and inflammation, Kiniksa is advancing a growing portfolio of approved and investigational medicines, anchored by its lead product, ARCALYST®, the first and only FDA‑approved therapy for recurrent pericarditis. Grounded in rigorous science and bold innovation, the company fosters a highly collaborative, patient‑first culture led by accomplished life sciences leaders. At Kiniksa, talented individuals are trusted and empowered to make a real impact—shaping the future of medicine while improving the lives of patients who need it most.

Kiniksa Pharmaceuticals is seeking a highly experienced Director, Medical Writing to serve as a senior individual contributor supporting clinical development programs through clear, high-quality, and scientifically robust medical writing.

This role is central to delivering clinical narratives that are accurate, aligned, and impactful, enabling teams to make informed decisions and advance programs efficiently. In addition to leading document development, the Director will contribute to the evolution of the medical writing function’s strategy, helping drive quality, speed, and consistency across the portfolio.

This role is based in our Lexington, MA office and requires employees to be onsite five days per week.

Responsibilities (including, but not limited to):

Clinical & Medical Writing Leadership

- Lead the planning, authoring, and review of key clinical documents, including:
- Clinical study reports (CSRs)
- Protocols and amendments
- Investigator’s Brochures (IBs)
- Clinical summaries and other program-level deliverables
- Translate complex clinical and statistical data into clear, concise, and scientifically compelling narratives
- Serve as a trusted writing expert within cross-functional teams

Scientific Quality & Narrative Excellence

- Ensure all documents meet the highest standards for clarity, accuracy, consistency, and interpretability
- Drive alignment of clinical messaging and data interpretation across documents and stakeholders
- Minimize rework through thoughtful structuring, early alignment, and strong storytelling

Cross-Functional Partnership

- Partner closely with Clinical Development, Clinical Operations, Biostatistics, and Safety to:
- Align early on document strategy and key messages
- Ensure consistency across program communications
- Facilitate efficient review cycles and timely delivery
- Act as a bridge between data and communication, enabling teams to focus on science while ensuring content excellence

Medical Writing Function Strategy & Excellence

- Contribute to the evolution of the medical writing function, aligned with the writing departments principles of:
- Working together: building strong partnerships and early alignment
- Doing it right: embedding quality into all deliverables
- Moving fast: enabling efficient, timely document delivery
- Support development and refinement of templates, tools, and best practices
- Help drive initiatives that improve:
- Document quality and consistency
- Speed and efficiency of delivery
- Cross-program alignment of messaging

Process Improvement & Ways of Working

- Identify opportunities to simplify processes and reduce review burden
- Contribute to a culture of clear ownership, accountability, and continuous improvement
- Provide guidance to peers and external partners to elevate overall writing capability

Standout Skills for Impact:

## Key Competencies

- Exceptional scientific writing and storytelling ability
- High attention to detail with a focus on clarity and usability
- Ability to influence without authority and drive alignment
- Strong ownership mindset and ability to work autonomously
- Continuous improvement and solution-oriented thinking

This role directly contributes to

- Higher-quality documents with fewer review cycles
- Faster delivery timelines through better alignment and execution
- Clear, consistent clinical narratives across programs
- Enabling teams to focus on science while ensuring content is right, ready, and impactful

Qualifications and Experience:

- Degree in life sciences or related field
- 8–12+ years of experience in medical/clinical writing in biopharma or CRO
- Demonstrated expertise in authoring complex clinical documents independently
- Thorough knowledge of drug development, ICH guidelines, Good Clinical Practice, CTD/eCTD organization, health authority expectations, and relevant pharmaceutical regulations
- Strong ability to synthesize and communicate complex data clearly
- Experience working in cross-functional clinical development teams
- Excellent communication, organization, and stakeholder management skills

Compensation decisions are based on objective criteria including role responsibilities, experience/qualifications, internal equity, geographic location, and external market benchmarks.

Pay Range $225,000—$239,000 USD

Kiniksa is an Equal Opportunity employer and will consider you without regard to your race, color, religion, sex, sexual orientation, gender identity, transgender status, age, genetics, national origin, protected veteran status, or disability status, or any other legally protected category. We will ensure that individuals with disabilities are provided reasonable accommodation to participate in the job application or interview process, to perform essential job functions, and to receive other benefits and privileges of employment. Please contact us to request accommodation.

Kiniksa does not accept unsolicited resumes from staffing agencies or search firms. Any resumes submitted without a signed agreement will be considered property of Kiniksa, and no fees will be paid.

## About Kiniksa Pharmaceuticals

## Company Overview
- **One-liner**: Kiniksa Pharmaceuticals is a global biopharmaceutical company focused on discovering, developing, and commercializing novel, transformative therapies for patients with significant unmet medical needs, with a primary focus on cardiovascular diseases and immune modulation.
- **Entity Type**: Public (NASDAQ: KNSA)
- **Headquarters**: Lexington, Massachusetts, USA (with additional offices in La Jolla, CA; Zug, Switzerland; and London, UK)
- **Founded**: 2015
- **Founders**: Sanj K. Patel (CEO & Chairman)

## Core Business
- **Primary industry/industries**: Biopharmaceuticals, Biotechnology
- **Target customers**: Patients, healthcare providers, and payers (B2B/B2C model in specialty pharma)
- **Mission or purpose statement**: Dedicated to placing patients first and driving innovation in novel, life-changing therapies to address unmet medical need. The company operates under the belief that "every second makes a difference for patients living with debilitating diseases."

## Products & Services
- **ARCALYST® (rilonacept)**: An FDA-approved treatment for recurrent pericarditis — the first and only FDA-approved therapy for this indication. It is an interleukin-1 alpha and beta cytokine trap.
- **Mavrilimumab**: A clinical-stage anti-GM-CSF receptor alpha monoclonal antibody. A Phase 2 trial in non-mechanically ventilated severe COVID-19 patients yielded positive results. Kiniksa and Huadong Medicine have a collaboration to develop and commercialize it in the Asia Pacific region (excluding Japan).
- **Vixarelimab**: A clinical-stage asset acquired via a global license agreement with Roche and Genentech. It has received FDA Breakthrough Therapy designation for pruritus associated with prurigo nodularis.
- **KPL-404**: A clinical-stage asset for which Kiniksa has initiated a first-in-human study with an antigen challenge (TDAR).

## Market Standing
- **Valuation/Market Cap**: Approximately $1.7 billion (as of mid-2026)
- **Key Metric**: Annual Revenue of $677.6 million (as of mid-2026); Total Funding raised ~$80M in Series A and $170.7M in gross IPO proceeds (2018)
- **Notable Investors/Partners**: Huadong Medicine (Asia Pacific collaboration), Roche, Genentech
- **Growth Signals**: FDA approvals and breakthrough designations, expanding global footprint (UK, Switzerland, Netherlands offices), headcount of 310 employees and growing, active job postings (36 as of mid-2026)

## Competitive Advantages
- **Approved Commercial Product**: ARCALYST® is the first and only FDA-approved therapy for recurrent pericarditis, creating a strong market foothold and revenue stream.
- **Strong Pipeline**: Combination of FDA-approved therapy and clinical-stage assets with strong biologic rationale and validated pathways.
- **Strategic Collaborations**: Partnerships with Roche/Genentech and Huadong Medicine provide access to global markets and cutting-edge science.
- **Leadership**: Led by a team of distinguished life sciences leaders with over 30 years of combined industry experience.

## Strategic Focus
- **Current priorities**: Commercializing ARCALYST® and expanding its indications; advancing the pipeline of clinical-stage assets (mavrilimumab, vixarelimab, KPL-404); expanding global presence (especially in Asia Pacific and Europe); pursuing further strategic acquisitions and collaborations.
- **Patient-centric innovation**: Focus on immune modulation targeting unmet needs and underserved conditions.

## Why Work Here
- **Culture**: Fosters a culture of passion, innovation, and rapid execution. Employees are described as "highly skilled, driven people advancing their careers—and making a difference in patients' lives."
- **Commitment to employees**: Kiniksa is intentional about cultivating a highly skilled and passionate team determined to deliver on its promise to patients.
- **Work environment**: Global company with offices in the US (Lexington, MA; La Jolla, CA), Switzerland (Zug), and the UK (London). The company offers a collaborative, science-driven environment.
- **Diversity, Equity, and Inclusion**: Committed to creating a culture of equality that celebrates diversity and fosters innovation; an Equal Opportunity Employer.
- **Perks & Benefits (US)**:
    - **Healthcare & Well-being**: Robust PPO medical insurance (Blue Cross Blue Shield) with HRA to cover deductible; dental (including orthodontia); vision; flexible spending accounts; fertility benefits and parental leave (up to 10 weeks at 100% pay, plus 6-8 weeks disability for birth parents); behavioral health support via EAP; and mental health programs.
    - **Financial & Protection**: 401k with traditional and Roth options through Fidelity, with immediate company match; Employee Stock Purchase Plan (15% discount); employer-paid life and AD&D insurance; short- and long-term disability coverage; voluntary additional life insurance.
    - **Work-Life Balance**: Paid sick and vacation time; company-paid holidays; company-sponsored events and volunteer opportunities.
    - **Other**: Subsidized lunches; employee referral program; starting coverage on the first day of employment.

## Sources
1. [Kiniksa Pharmaceuticals - About Us](https://www.kiniksa.com/about)
2. [Kiniksa Pharmaceuticals - Join Us](https://www.kiniksa.com/join-us)
3. [Kiniksa Pharmaceuticals - Leadership](https://www.kiniksa.com/leadership)
4. [Kiniksa Pharmaceuticals - LinkedIn Company Page](https://www.linkedin.com/company/kiniksa-pharmaceuticals)
5. [Kiniksa Pharmaceuticals - Main Site](https://www.kiniksa.com/)

## Other roles at Kiniksa Pharmaceuticals

- [Associate Director, Commercial Insights & Analytics](https://feeny.ai/job/associate-director-commercial-insights-analytics-kiniksa-pharmaceuticals-6wdz3v049ar6) — Lexington, MA
- [Assoc. Director, Quality Management Systems](https://feeny.ai/job/assoc-director-quality-management-systems-kiniksa-pharmaceuticals-lexington-sgeh0ans7am4) — Lexington, MA
- [Assoc. Director, Clinical Quality Assurance](https://feeny.ai/job/assoc-director-clinical-quality-assurance-kiniksa-pharmaceuticals-lexington-0qmsbr1k9dfj) — Lexington, MA
- [Clinical Sales Specialist-Phoenix](https://feeny.ai/job/clinical-sales-specialist-phoenix-kiniksa-pharmaceuticals-phoenix-w7rensy8mm79) — Phoenix, AZ
- [Clinical Sales Specialist-Tucson](https://feeny.ai/job/clinical-sales-specialist-tucson-kiniksa-pharmaceuticals-tucson-zgq19bbc9pr2) — Tucson, AZ
- [Clinical Sales Specialist- San Jose](https://feeny.ai/job/clinical-sales-specialist-san-jose-kiniksa-pharmaceuticals-field-tkgmyvb7w4hz) — Field
- [Clinical Sales Specialist- Southern Colorado](https://feeny.ai/job/clinical-sales-specialist-southern-colorado-kiniksa-pharmaceuticals-field-0av43m0vtzxt) — Field
- [Clinical Sales Specialist- Kentucky](https://feeny.ai/job/clinical-sales-specialist-kentucky-kiniksa-pharmaceuticals-field-38zz57hg9k0p) — Field
- [CMC Project Manager](https://feeny.ai/job/cmc-project-manager-kiniksa-pharmaceuticals-lexington-vwrkbs252sf5) — Lexington, MA
- [Sr. Director, Clinical Supply Chain Management and Systems](https://feeny.ai/job/sr-director-clinical-supply-chain-management-and-systems-kiniksa-8szgtwx1s3fm) — Lexington, MA